ACCELERON PHARMA INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
ACCELERON PHARMA INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $366.67 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2021-11-04
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $366.67M.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $236.60M.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $284.02M.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $264.05M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2021-09-30 | $366.67M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $236.60M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $284.02M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $264.05M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $238.80M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $192.69M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $210.03M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $64.15M 10-K · filed 2020-02-27 |
| 2019-09-30 | $18.73M 10-Q · filed 2019-11-06 |
| 2018-12-31 | $33.44M 10-K · filed 2019-02-27 |
| 2017-12-31 | $46.12M 10-K · filed 2018-02-27 |
| 2016-12-31 | $18.56B 10-K · filed 2017-03-01 |
| 2015-12-31 | $95.48B 10-K · filed 2016-02-25 |
| 2015-06-30 | $57.87M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $81.16M 10-Q · filed 2015-05-07 |